Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

NCT: NCT07422675 · RECRUITING

NCT IDNCT07422675
StatusRECRUITING
Start Date2026-02-01
Completion2027-01-31

Brief Summary

This is a randomized, placebo-controlled, single ascending dose (SAD) study of SER-252 in participants with Parkinson's Disease (PD) and motor fluctuations.

Frequently Asked Questions

What is SAD Study in Patients With Parkinson's Disease and Motor Fluctuations?

SAD Study in Patients With Parkinson's Disease and Motor Fluctuations is a clinical trial registered under NCT07422675. Current status: RECRUITING.

What is the status of NCT07422675?

The current status of NCT07422675 (SAD Study in Patients With Parkinson's Disease and Motor Fluctuations) is: RECRUITING.

When did SAD Study in Patients With Parkinson's Disease and Motor Fluctuations start?

SAD Study in Patients With Parkinson's Disease and Motor Fluctuations started on 2026-02-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑